Optimization of Melanoma Skin Cancer Detection with the Convolutional Neural Network
Journal Medical Informatics Technology · 2023
DOI: 10.37034/medinftech.v1i2.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal Medical Informatics Technology, 2023. Verfasst von Harming Puja Kekal und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Currently, skin cancer is a very dangerous disease for humans. Skin cancer is classified into many types such as Melanoma, Basal and Squamous cell carcinoma. In all types of cancer, melanoma is the most dangerous and unpredictable disease. Detection of melanoma cancer at an early stage is useful for effective treatment and can be used to classify types of melanoma cancer. New innovations in the classification and detection of skin cancer using artificial neural networks continue to develop to assist the medical and medical world in analyzing images precisely and accurately. The method used in this research is Convolutional Neural Network (CNN) with MobileNet model architecture. Skin cancer detection consists of five important stages, namely image database collection, preprocessing methods, augmentation data, model training and model evaluation. This evaluation was carried out using the MobileNet method with an accuracy of 88%.
Zitieren
APA
Kekal, H. P., & Saputri, D. U. E. (2023). Optimization of Melanoma Skin Cancer Detection with the Convolutional Neural Network. Journal Medical Informatics Technology. https://doi.org/10.37034/medinftech.v1i2.10
Vancouver
Kekal HP, Saputri DUE. Optimization of Melanoma Skin Cancer Detection with the Convolutional Neural Network. Journal Medical Informatics Technology. 2023. doi:10.37034/medinftech.v1i2.10
BibTeX
@article{Kekal2023,
author = {Kekal, Harming Puja and Saputri, Daniati Uki Eka},
title = {Optimization of Melanoma Skin Cancer Detection with the Convolutional Neural Network},
journal = {Journal Medical Informatics Technology},
year = {2023},
doi = {10.37034/medinftech.v1i2.10}
}
EUVIMED